The Journal of Allergy and Clinical Immunology
Volume 126, Issue 3 , Pages 648-656.e4, September 2010

Arabinogalactan isolated from cowshed dust extract protects mice from allergic airway inflammation and sensitization

  • Marcus Peters, PhD

      Affiliations

    • Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany
    • Corresponding Author InformationReprint requests: Marcus Peters, PhD, Department of Experimental Pneumology, Ruhr-University Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
  • ,
  • Marion Kauth, PhD

      Affiliations

    • Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany
    • Protectimmun GmbH, Bochum, Germany
  • ,
  • Olaf Scherner, PhD

      Affiliations

    • Protectimmun GmbH, Bochum, Germany
  • ,
  • Kirsten Gehlhar, PhD

      Affiliations

    • Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany
  • ,
  • Imke Steffen, MSc

      Affiliations

    • Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany
  • ,
  • Pia Wentker, MSc

      Affiliations

    • Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany
  • ,
  • Erika von Mutius, MD

      Affiliations

    • Dr von Hauner Children's Hospital, Munich, Germany
  • ,
  • Otto Holst, PhD

      Affiliations

    • Department of Structural Biochemistry, Research Center Borstel, Borstel, Germany
  • ,
  • Albrecht Bufe, MD, PhD

      Affiliations

    • Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany

Received 7 January 2010; received in revised form 29 April 2010; accepted 7 May 2010. published online 12 July 2010.

Background

Extract from cowshed dust (CDE) is a source of immunomodulating substances. We have previously shown that such substances protect from experimental allergic disorders in a mouse model of asthma.

Objective

The objective of this study was to identify immunomodulatory molecules in extracts of dust from an allergy protective farming environment.

Methods

Polysaccharides were isolated from CDE and plants by chromatography and precipitation with specific reagents. Polysaccharides were then characterized by nuclear magnetic resonance spectroscopy. Subsequently, the allergy-protective potential of isolated polysaccharides was tested in a mouse model of asthma.

Results

The authors demonstrate that plant arabinogalactans are contained in CDE in high concentrations. The source of this arabinogalactan is fodder, in particular a prevalent grass species known as Alopecurus pratensis. Treatment of murine dendritic cells with grass arabinogalactan resulted in autocrine IL-10 production. Interestingly, these dendritic cells were not able to induce an allergic immune response. Furthermore, intranasal application of grass arabinogalactan protected mice from developing atopic sensitization, allergic airway inflammation and airway hyperreactivity in a mouse model of allergic asthma. This allergy-protective effect is specific for grass arabinogalactan because control experiments with arabinogalactan from gum arabic and larch revealed that these molecules do not show allergy-protective properties. This is likely because of structural differences because we were able to show by nuclear magnetic resonance spectroscopy that although they are predominantly composed of arabinose and galactose, the molecules differ in structure.

Conclusions

The authors conclude that grass arabinogalactans are important immunomodulatory substances that contribute to the protection from allergic airway inflammation, airway hyperresponsiveness, and atopic sensitization in a mouse model of asthma.

Key words: Allergic airway inflammation, sensitization, immunomodulation, arabinogalactan

Abbreviations used: AG/BMDC, Arabinogalactan treated bone marrow–derived dendritic cells, BAL, Bronchoalveolar lavage, BMDC, Bone marrowderived dendritic cell, CDE, Cowshed dust extract, DC, Dendritic cell, D-Galp, D-galactopyranose, L-Araf, L-arabinofuranose, NMR, Nuclear magnetic resonance, OVA, Ovalbumin, P1, High-molecular-mass fraction

 

 Supported by Deutsche Forschungsgemeinschaft (DFG: BU-762/5-1, HO-1259/4-1), intramural research funding of Ruhr-University Bochum (FoRUM 476-2005), the European Commission as part of GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community), and Protectimmun GmbH.

 Disclosure of potential conflict of interest: E. von Mutius has consulted for Glaxo SmithKline, UCB, and Protectimmun and has received research support from Airsonett AB. O. Holst has received research support from Deutsche Forschungsgemeinschaft and the European Union. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(10)00812-2

doi:10.1016/j.jaci.2010.05.011

The Journal of Allergy and Clinical Immunology
Volume 126, Issue 3 , Pages 648-656.e4, September 2010